| Prod'homme, Virginie  ORCID: https://orcid.org/0000-0002-9664-4710, Griffin, Cora, Aicheler, Rebecca, Wang, Edward Chung Yern  ORCID: https://orcid.org/0000-0002-2243-4964, McSharry, Brian Patrick, Rickards, Carole Ruth, Stanton, Richard James  ORCID: https://orcid.org/0000-0002-6799-1182, Borysiewicz, Leszek K., Lopez-Botet, Miguel, Wilkinson, Gavin William Grahame  ORCID: https://orcid.org/0000-0002-5623-0126 and Tomasec, Peter
      2007.
      
      The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1- NK Cells.
      The Journal of Immunology
      178
      
        (7)
      
      , pp. 4473-4481. | 
Abstract
The inhibitory leukocyte Ig-like receptor 1 (LIR-1, also known as ILT2, CD85j, or LILRB1) was identified by its high affinity for the human CMV (HCMV) MHC class I homolog gpUL18. The role of this LIR-1-gpUL18 interaction in modulating NK recognition during HCMV infection has previously not been clearly defined. In this study, LIR-1(+) NKL cell-mediated cytotoxicity was shown to be inhibited by transduction of targets with a replication-deficient adenovirus vector encoding UL18 (RAd-UL18). Fibroblasts infected with an HCMV UL18 mutant (DeltaUL18) also exhibited enhanced susceptibility to NKL killing relative to cells infected with the parental virus. In additional cytolysis assays, UL18-mediated protection was also evident in the context of adenovirus vector transduction and HCMV infection of autologous fibroblast targets using IFN-alpha-activated NK bulk cultures derived from a donor with a high frequency of LIR-1(+) NK cells. A single LIR-1(high) NK clone derived from this donor was inhibited by UL18, while 3 of 24 clones were activated. CD107 mobilization assays revealed that LIR-1(+) NK cells were consistently inhibited by UL18 in all tested donors, but this effect was often masked in the global response by UL18-mediated activation of a subset of LIR-1(-) NK cells. Although Ab-blocking experiments support UL18 inhibition being induced by a direct interaction with LIR-1, the UL18-mediated activation is LIR-1 independent.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI) | 
| Publisher: | American Association of Immunologists | 
| ISSN: | 0022-1767 | 
| Last Modified: | 17 Oct 2022 08:29 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/294 | 
Citation Data
Cited 118 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
|  | Edit Item | 

 
							

 CORE (COnnecting REpositories)
 CORE (COnnecting REpositories) CORE (COnnecting REpositories)
 CORE (COnnecting REpositories)